Moderna Inc (MRNA) Stock Analysis

Moderna Inc (MRNA) is a publicly traded company in the HEALTHCARE sector. It trades at $45.64, carries a market capitalization of $18.28B. This page summarizes the public market data, fundamentals, and frequently asked questions for MRNA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Moderna Inc currently has a Bullish sentiment score of 0.17.

About Moderna Inc

Moderna, Inc. is a pioneering biotechnology company based in Cambridge, Massachusetts, recognized for its innovative approach to messenger RNA (mRNA) technology in vaccine and therapeutic development. Gaining global prominence for its role in delivering one of the first successful COVID-19 vaccines, Moderna is now strategically expanding its portfolio to target a wide array of health challenges, including immuno-oncology, rare diseases, cardiovascular conditions, and autoimmune disorders. Wit...

GNG Research Analysis

GNG Research scores Moderna Inc (MRNA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MRNA.

Frequently Asked Questions

Does MRNA pay dividends?

Moderna Inc (MRNA) does not currently pay a regular dividend.

What is MRNA's market cap?

Moderna Inc (MRNA) has a market capitalization of $18.28B with a current stock price of $45.64.